BioXcel Therapeutics, Inc. (BTAIQ) — Dilution Risk Analysis
Current Snapshot
BioXcel Therapeutics, Inc. (BTAIQ) has a DilutionWatch score of 74/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 74/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: SC 13G/A 1, 3 1, 4 1, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| SC 13G/A | 2026-08-14 | 0001172661-26-003557 |
| 3 | 2026-08-14 | 0001104659-26-097387 |
| 4 | 2026-08-14 | 0001104659-26-097388 |
| xbrl | 2026-06-30 | xbrl-12076-xbrl_warrant |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 1 months | Source |
| Three-year share count growth | 755.56% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 74/10) Source
- Cash Runway
- 1 months Source
- Share Count Growth (3-Year)
- 755.56% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.